Associated Papers
In Vivo Functional Effects of CYP2C9 M1L, a Novel and Common Variant in the Yup'ik Alaska Native Population.
Henderson LM et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals, 2021
Heterologous Expression and Functional Characterization of Novel CYP2C9 Variants Identified in the Alaska Native People.
McDonald MG et al.
The Journal of Pharmacology and Experimental Therapeutics, 2020
VKORC1 and Novel CYP2C9 Variation Predict Warfarin Response in Alaska Native and American Indian People.
Henderson LM et al.
Clinical and Translational Science, 2019
Cytochrome P450 Genetic Variation Associated with Tamoxifen Biotransformation in American Indian and Alaska Native People.
Khan BA et al.
Clinical and Translational Science, 2018
P450 Pharmacogenetics in Indigenous North American Populations.
Henderson LM et al.
Journal of Personalized Medicine, 2018
Pharmacogenomics of CYP2C9: Functional and Clinical Considerations.
Daly AK et al.
Journal of Personalized Medicine, 2017
Warfarin Pharmacogenomics in Diverse Populations.
Kaye JB et al.
Pharmacotherapy, 2017
Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX.
Fohner AE et al.
Pharmacogenetics and Genomics, 2015
Select a paper to view details